Logo

Similar Products

Description

Premium Tamoxifen Tablets IP 10mg represent a critical pharmaceutical product manufactured in strict compliance with Indian Pharmacopoeia (IP) standards. Each tablet contains 10mg ...
Premium Tamoxifen Tablets IP 10mg represent a critical pharmaceutical product manufactured in strict compliance with Indian Pharmacopoeia (IP) standards. Each tablet contains 10mg of Tamoxifen Citrate as the active pharmaceutical ingredient, formulated to deliver precise and effective hormonal therapy for breast cancer treatment. The manufacturing process incorporates rigorous quality control measures at every stage, ensuring consistent dosage accuracy, purity, and therapeutic performance batch after batch. Produced under hygienic conditions that meet current Good Manufacturing Practices (cGMP), these tablets offer reliable medication that healthcare professionals can confidently prescribe. The stable formulation and appropriate packaging ensure extended shelf life and suitability for global distribution, storage, and use across various clinical environments.

This medication serves as a fundamental therapeutic agent primarily within oncology, women's health, and specialized medical sectors. Hospital networks, comprehensive cancer centers, oncology clinics, and outpatient treatment facilities worldwide utilize these tablets for managing hormone receptor-positive breast cancer. Gynecology departments integrate them into holistic treatment plans, while research institutions may employ them in clinical studies and therapeutic evaluations. The product fulfills the requirements of diverse healthcare systems, including government-run hospitals, private healthcare providers, and medical institutions seeking dependable, high-quality cancer treatment medications that adhere to recognized international quality and safety benchmarks.

Business partners benefit from our unwavering commitment to reliability, quality assurance, and consistent supply chain management. We implement strict quality assurance protocols that verify every production batch meets specified pharmaceutical standards, providing distributors and healthcare providers with complete confidence in the product. Our manufacturing excellence, backed by comprehensive documentation including certificates of analysis, ensures product safety and efficacy. We maintain a robust and reliable supply chain to guarantee uninterrupted availability, making us a trusted partner for distributors and wholesalers serving the essential needs of healthcare providers and patients. Our focus on consistent quality and dependable delivery supports your business in meeting critical healthcare demands.

Key Features:
- Manufactured to exacting Indian Pharmacopoeia (IP) quality standards for assured pharmaceutical excellence
- Precise 10mg Tamoxifen Citrate dosage per tablet enabling accurate and flexible treatment regimens
- Comprehensive quality control testing throughout production ensures batch-to-batch consistency and reliability
- Stable formulation with optimized shelf life, suitable for international distribution and storage
- Produced in cGMP-compliant facilities ensuring the highest standards of safety and quality

Benefits:
- Delivers reliable and effective hormonal therapy for hormone receptor-positive breast cancer treatment
- Provides healthcare professionals with a trusted medication for personalized patient care plans
- Ensures consistent therapeutic performance and dosage accuracy for predictable treatment outcomes
- Offers a dependable supply of a critical medication for hospitals, clinics, and pharmacies
- Supports distributors with a high-quality product backed by rigorous manufacturing and quality standards

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Tamoxifen Tablets IP 10mg are a cornerstone hormonal therapy for hormone receptor-positive breast cancer. The 10mg dosage provides precise estrogen blockade, inhibiting cancer cell proliferation and offering flexible treatment regimens that medical professionals can tailor to individual patient needs across various clinical stages and protocols. This allows for personalized therapeutic approaches in diverse healthcare settings.

This medication is essential for oncology departments, hospital pharmacies, and specialized cancer treatment centers globally. Healthcare providers prescribe these tablets for managing both early-stage and advanced metastatic breast cancer, as well as for preventive care in high-risk patient populations. The product meets stringent international pharmaceutical standards, delivering consistent therapeutic efficacy that medical institutions rely upon for critical treatment plans and patient care continuity.
- Adjuvant therapy following surgery for early-stage hormone receptor-positive breast cancer in postmenopausal women
- Primary treatment for advanced or metastatic breast cancer in both premenopausal and postmenopausal patients
- Risk reduction therapy for women with significant family history or genetic predisposition to breast cancer
- Management of ductal carcinoma in situ (DCIS) to prevent invasive cancer development
- Treatment for other estrogen-sensitive conditions under specialist medical guidance and supervision

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
Verified
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Premium Tamoxifen Tablets IP 10mg Breast Cancer Treatment

Premium Tamoxifen Tablets IP 10mg breast cancer treatment medication manufactured to Indian Pharmacopoeia standards for reliable supply to hospitals, clinics, and pharmacies worldwide.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier

Related Products